Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the US-Reference-Cited by-同舟云学术

Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the US

Published:2017-10-02 Issue:3-4 Volume:31 Page:218-227
ISSN:1536-0288
Container-title:Journal of Pain & Palliative Care Pharmacotherapy
language:en
Short-container-title:Journal of Pain & Palliative Care Pharmacotherapy

Author:

Banerjee Souvik^ORCID,Roland Carl L.,Willke Richard,Mardekian Jack,Garrison Louis P.

Funder

Pfizer Inc.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Anesthesiology and Pain Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15360288.2017.1407860

Reference14 articles.

1. The Economic Costs of Pain in the United States

2. New York Times. F.D.A. approval of OxyContin use for children continues to draw scrutiny. http://www.nytimes.com/2015/10/09/health/fda-approval-of-oxycontin-for-children-continues-to-draw-scrutiny.html?_r = 0. Published October 8, 2015. Accessed March 11, 2016.

3. A Proactive Response to Prescription Opioid Abuse

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Claims-based measures of prescription opioid utilization: A practical guide for researchers;Drug and Alcohol Dependence;2021-11

2. Filled prescriptions for opioids among children and adolescents – A nationwide study from 2010 to 2018;Acta Anaesthesiologica Scandinavica;2021-08-26

3. Assessment of Prescription Opioid Medical Use and Misuse Among Parents and Their Adolescent Offspring in the US;JAMA Network Open;2021-01-07

4. Correlates and motivations of prescription opioid use among adolescents 12 to 17 years of age in the United States;Pain;2019-12-04

5. Prescription opioid dispensing in Australian children and adolescents: a national population-based study;The Lancet Child & Adolescent Health;2019-12